TORONTO, March 19, 2026 /CNW/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") announced ...

The Nevada-focused gold miner said Thursday it plans to offer $250 million of convertible senior notes due 2031, or up to $287.5 million if an option granted to initial purchasers to buy additional ...

CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount ...

Nebius Group N.V. ("Nebius Group" or the "Company"; NASDAQ: NBIS), a leading AI infrastructure company, today announced the pricing of its offering of $4.0 billion aggregate original principal amount ...

Ormat Technologies (ORA) is raising up to $975.7M through private convertible notes due 2031, including $725M in 1.50% Series A notes and $150M in 0% Series B notes, up from its earlier $750M plan, ...

Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due ...

I-80 Gold is selling $200 million of convertible bonds to help advance the miner's five gold projects, refurbish a processing plant and fund the expansion of its resource base. The Nevada-focused gold ...

CRISPR Therapeutics (CRSP) upsized a $550M convertible notes deal due 2031 at 1.125%, with a 45% conversion premium—get the key terms now.

Duke Energy (DUK) prices $1.3B 2029 convertible notes at 3% to refinance 2026 notes; see terms, conversion price/premium, and what it means—read now.

Nebius plans a $3.75 billion convertible notes offering to expand AI infrastructure after major deals with Meta and Nvidia.

Indivior Pharmaceuticals (INDV) has announced the pricing of its offering of $450M in convertible senior notes due in 2031. The offering size was increased from an initial amount of $400M.

Detailed price information for Indivior Pharmaceuticals Inc (INDV-Q) from The Globe and Mail including charting and trades.